Findings

What do systematic reviews say?

24 questions · 25 findings · 3 reviews · Neuromuscular

Sort:Best matchNewest Highest certainty Download CSV

No studies found 7 · 28%GRADE not reported 2 · 8%Very low 2 · 8%Low 5 · 20%Moderate 9 · 36%High 0 · 0%

Prednisone vs prednisone and plasma exchange (Gajdos 1983)

Score (MMS) day 30

1 finding from 1 review

Plasma exchange for generalised myasthenia gravis 2002 · Cochrane Headline outcomes only
no estimate extracted
1 study · 14 participants
Low

Prednisone vs prednisone and plasma exchange (Gajdos 1983)

Score (MMS) month 12

1 finding from 1 review

Plasma exchange for generalised myasthenia gravis 2002 · Cochrane Headline outcomes only
no estimate extracted
1 study · 14 participants
Low

Prednisone vs placebo

Activity limitations ‐ not measured · people with postpolio syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Treatment for postpolio syndrome 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Prednisone vs placebo

Adverse events · people with postpolio syndrome

1 finding from 1 review

Treatment for postpolio syndrome 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 17 participants
GRADE not reported

Corticosteroids vs placebo

Mean change in average muscle score: prednisone ‐ daily dose regimen (0.75 mg/kg/day) · patients with Duchenne muscular dystrophy

1 finding from 1 review

Corticosteroids for the treatment of Duchenne muscular dystrophy 2016 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 147 participants
Moderate

Corticosteroids vs placebo

Nine‐metre walking/running time: prednisone ‐ daily dose regimen (0.75 mg/kg/day) · patients with Duchenne muscular dystrophy

1 finding from 1 review

Corticosteroids for the treatment of Duchenne muscular dystrophy 2016 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 111 participants
Moderate

Corticosteroids vs placebo

4‐stair climbing time: prednisone ‐ daily dose regimen (0.75 mg/kg/day) · patients with Duchenne muscular dystrophy

1 finding from 1 review

Corticosteroids for the treatment of Duchenne muscular dystrophy 2016 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 152 participants
Moderate

Corticosteroids vs placebo

Weight gain · patients with Duchenne muscular dystrophy

1 finding from 1 review

Corticosteroids for the treatment of Duchenne muscular dystrophy 2016 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 126 participants
Moderate

Corticosteroids vs placebo

Behavioural changes ‐ prednisone (0.75 mg/kg/day) · patients with Duchenne muscular dystrophy

Corticosteroids showed no clear difference in behavioural changes ‐ prednisone (0.75 mg/kg/day) compared with placebo (moderate certainty).

1 finding from 1 review

Corticosteroids for the treatment of Duchenne muscular dystrophy 2016 · Cochrane Headline outcomes only
RR 1.39 [0.94, 2.06]
2 studies · 135 participants
Moderate

Weekend‐only vs prednisone

Change in muscle strength ‐ QMT leg score (lb) · patients with Duchenne muscular dystrophy

1 finding from 1 review

Corticosteroids for the treatment of Duchenne muscular dystrophy 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 57 participants
Moderate

Weekend‐only vs prednisone

Muscle strength · patients with Duchenne muscular dystrophy

2 findings from 1 review

Corticosteroids for the treatment of Duchenne muscular dystrophy 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 54 participants
Low
Corticosteroids for the treatment of Duchenne muscular dystrophy 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 57 participants
Moderate

Weekend‐only vs prednisone

Change in 10‐metre walking time · patients with Duchenne muscular dystrophy

1 finding from 1 review

Corticosteroids for the treatment of Duchenne muscular dystrophy 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 56 participants
Moderate

Weekend‐only vs prednisone

Change in 4‐stair climbing time · patients with Duchenne muscular dystrophy

1 finding from 1 review

Corticosteroids for the treatment of Duchenne muscular dystrophy 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 55 participants
Moderate

Weekend‐only vs prednisone

Body‐mass index (BMI) · patients with Duchenne muscular dystrophy

1 finding from 1 review

Corticosteroids for the treatment of Duchenne muscular dystrophy 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 58 participants
Low

Weekend‐only vs prednisone

Behavioural changes · patients with Duchenne muscular dystrophy

1 finding from 1 review

Corticosteroids for the treatment of Duchenne muscular dystrophy 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 54 participants
Low

Weekend‐only vs prednisone

Fractures ‐ not reported · patients with Duchenne muscular dystrophy

1 finding from 1 review

Corticosteroids for the treatment of Duchenne muscular dystrophy 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 53 participants
GRADE not reported

Deflazacort vs prednisone

Prolongation of time to loss of ambulation ‐ not reported · patients with Duchenne muscular dystrophy

The review found no eligible studies for this question.

1 finding from 1 review

Corticosteroids for the treatment of Duchenne muscular dystrophy 2016 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Deflazacort vs prednisone

Muscle strength ‐ not reported · patients with Duchenne muscular dystrophy

The review found no eligible studies for this question.

1 finding from 1 review

Corticosteroids for the treatment of Duchenne muscular dystrophy 2016 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Deflazacort vs prednisone

Change in 10‐metre walking time · patients with Duchenne muscular dystrophy

The review found no eligible studies for this question.

1 finding from 1 review

Corticosteroids for the treatment of Duchenne muscular dystrophy 2016 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Deflazacort vs prednisone

Change in 4‐stair climbing time · patients with Duchenne muscular dystrophy

The review found no eligible studies for this question.

1 finding from 1 review

Corticosteroids for the treatment of Duchenne muscular dystrophy 2016 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found